JP2002503250A - 血小板懸濁物および血小板を再懸濁するための方法 - Google Patents

血小板懸濁物および血小板を再懸濁するための方法

Info

Publication number
JP2002503250A
JP2002503250A JP50247199A JP50247199A JP2002503250A JP 2002503250 A JP2002503250 A JP 2002503250A JP 50247199 A JP50247199 A JP 50247199A JP 50247199 A JP50247199 A JP 50247199A JP 2002503250 A JP2002503250 A JP 2002503250A
Authority
JP
Japan
Prior art keywords
platelet
platelets
plasma
solution
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP50247199A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002503250A5 (cg-RX-API-DMAC7.html
Inventor
エル. カンドラー,リチャード
シー. ファレル,リアム
Original Assignee
バクスター インターナショナル インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バクスター インターナショナル インコーポレイテッド filed Critical バクスター インターナショナル インコーポレイテッド
Publication of JP2002503250A publication Critical patent/JP2002503250A/ja
Publication of JP2002503250A5 publication Critical patent/JP2002503250A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP50247199A 1997-06-09 1998-05-15 血小板懸濁物および血小板を再懸濁するための方法 Ceased JP2002503250A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/871,115 US6063624A (en) 1997-06-09 1997-06-09 Platelet suspensions and methods for resuspending platelets
US08/871,115 1997-06-09
PCT/US1998/010029 WO1998056247A1 (en) 1997-06-09 1998-05-15 Platelet suspensions and methods for resuspending platelets

Publications (2)

Publication Number Publication Date
JP2002503250A true JP2002503250A (ja) 2002-01-29
JP2002503250A5 JP2002503250A5 (cg-RX-API-DMAC7.html) 2005-12-08

Family

ID=25356764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50247199A Ceased JP2002503250A (ja) 1997-06-09 1998-05-15 血小板懸濁物および血小板を再懸濁するための方法

Country Status (7)

Country Link
US (3) US6063624A (cg-RX-API-DMAC7.html)
EP (1) EP1001675A4 (cg-RX-API-DMAC7.html)
JP (1) JP2002503250A (cg-RX-API-DMAC7.html)
AU (1) AU738348B2 (cg-RX-API-DMAC7.html)
BR (1) BR9810088A (cg-RX-API-DMAC7.html)
CA (1) CA2290389A1 (cg-RX-API-DMAC7.html)
WO (1) WO1998056247A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009226210A (ja) * 2008-02-29 2009-10-08 Haemonetics Corp アフェレーシス装置

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063624A (en) * 1997-06-09 2000-05-16 Baxter International Inc. Platelet suspensions and methods for resuspending platelets
US7498156B2 (en) * 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
AU9530101A (en) * 2000-10-16 2002-04-29 Univ Liege Medicinal composition and in particular its use in fluid therapy
US6548241B1 (en) 2000-11-28 2003-04-15 Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
US7011852B2 (en) * 2001-05-07 2006-03-14 Hemogenesis, Llc Separation of platelets from whole blood for use as a healant
US8101077B2 (en) * 2001-05-07 2012-01-24 Sivaprasad Sukavaneshvar Device for separating platelets from fluid suspensions
US7264608B2 (en) * 2001-12-05 2007-09-04 Fenwal, Inc. Manual processing systems and methods for providing blood components conditioned for pathogen inactivation
CA2482021C (en) * 2002-04-24 2007-06-19 Gambro, Inc. Removal of adenine during a process of pathogen reducing blood and blood components
US20040182795A1 (en) * 2003-03-21 2004-09-23 Randel Dorian Apparatus and method for concentration of plasma from whole blood
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US6905612B2 (en) * 2003-03-21 2005-06-14 Hanuman Llc Plasma concentrate apparatus and method
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
AU2003249642A1 (en) 2002-05-24 2003-12-12 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
AU2004249194B2 (en) * 2003-06-20 2009-07-16 Pall Corporation Processing of platelet-containing biological fluids
JP2007501255A (ja) * 2003-08-04 2007-01-25 ヒューマン バイオシステムズ 血液細胞の保存
US20050137517A1 (en) * 2003-12-19 2005-06-23 Baxter International Inc. Processing systems and methods for providing leukocyte-reduced blood components conditioned for pathogen inactivation
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
US7799754B2 (en) 2004-10-14 2010-09-21 Biomimetic Therapeutics, Inc. Compositions and methods for treating bone
WO2006086200A1 (en) * 2005-02-07 2006-08-17 Hanuman Llc Plasma concentrator device
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
EP2431060B1 (en) 2005-11-17 2020-04-08 BioMimetic Therapeutics, LLC Maxillofacial bone augmentation using RHPDGF-BB and a biocompatible matrix
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
ES2664229T3 (es) 2006-06-30 2018-04-18 Biomimetic Therapeutics, Llc Composiciones y métodos de biomatriz-PDGF para el tratamiento de lesiones del manguito rotador
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
DK1886559T3 (en) * 2006-07-31 2016-04-11 Canadian Blood Services Platelet additive solution
WO2008022651A1 (en) * 2006-08-21 2008-02-28 Antoine Turzi Process and device for the preparation of platelet rich plasma for extemporaneous use and combination thereof with skin and bone cells
JP5552315B2 (ja) 2006-11-03 2014-07-16 バイオミメティック セラピューティクス, エルエルシー アースロデティック術のための組成物および方法
US20080195476A1 (en) * 2007-02-09 2008-08-14 Marchese Michael A Abandonment remarketing system
US7964339B2 (en) * 2007-02-09 2011-06-21 Canadian Blood Services Cold storage of modified platelets
US8067151B2 (en) * 2007-02-09 2011-11-29 Canadian Blood Services Cold storage of pegylated platelets at about or below 0° C.
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
CN101868255A (zh) * 2007-08-01 2010-10-20 科安比司特生物技术有限责任公司 全血的病原体灭活
WO2009026073A1 (en) * 2007-08-22 2009-02-26 Caridianbct Biotechnologies, Llc Prevention of transfusion related acute lung injury using riboflavin and light
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
WO2009100454A1 (en) 2008-02-07 2009-08-13 Biomimetic Therapeutics, Inc. Compositions and methods for distraction osteogenesis
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) * 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
NZ602861A (en) 2008-09-09 2014-03-28 Biomimetic Therapeutics Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
WO2010039994A2 (en) * 2008-10-01 2010-04-08 Caridianbct, Inc. Platelet additive solution for leukoreducing white blood cells in apheresed platelets
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
CA2790403C (en) 2010-02-22 2019-08-27 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
JP2013524784A (ja) 2010-04-08 2013-06-20 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 血小板の保存のためのゼオドレーション法
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US11901069B2 (en) 2010-08-12 2024-02-13 Fenwal, Inc. Processing blood donation data for presentation on operator interface
US8485828B2 (en) * 2010-08-12 2013-07-16 Fenwal, Inc. Methods and systems for blood collection operator training
US8676600B2 (en) 2010-08-12 2014-03-18 Fenwal, Inc Mobile applications for blood centers
US9555171B2 (en) 2010-09-30 2017-01-31 Depuy Mitek, Llc Methods and devices for collecting separate components of whole blood
WO2012139017A1 (en) 2011-04-07 2012-10-11 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
CN103906429B (zh) 2011-05-03 2015-09-02 汾沃有限公司 血小板的重悬浮方法和装置
WO2013111130A1 (en) 2012-01-23 2013-08-01 Estar Technologies Ltd A system and method for obtaining a cellular sample enriched with defined cells such as platelet rich plasma(prp)
US20150355191A1 (en) 2012-07-11 2015-12-10 Biomimetic Therapeutics, Llc Cell-Based Assay for Neutralizing Antibodies
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
WO2020154305A1 (en) 2019-01-21 2020-07-30 Eclipse Medcorp, Llc Methods, systems and apparatus for separating components of a biological sample
US12007382B2 (en) 2019-10-31 2024-06-11 Crown Laboratories, Inc. Systems, methods and apparatus for separating components of a sample

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32874A (en) * 1861-07-23 Electro-magnet
CA1216518A (en) 1982-11-01 1987-01-13 Gail A. Rock Plasma-free medium for platelet storage
US4828976A (en) * 1983-12-29 1989-05-09 Thomas Jefferson University Glucose free media for storing blood platelets
US5234918A (en) * 1988-04-04 1993-08-10 American Cyanamid Company Certain phosphinyl-oxy-phenyl-methyl-pyridinium-hydroxide inner salts useful as antagonists of PAF
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
US5622867A (en) * 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
US6063624A (en) * 1997-06-09 2000-05-16 Baxter International Inc. Platelet suspensions and methods for resuspending platelets

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009226210A (ja) * 2008-02-29 2009-10-08 Haemonetics Corp アフェレーシス装置

Also Published As

Publication number Publication date
EP1001675A4 (en) 2004-10-13
EP1001675A1 (en) 2000-05-24
WO1998056247A1 (en) 1998-12-17
BR9810088A (pt) 2000-08-08
US6326197B1 (en) 2001-12-04
US6613566B2 (en) 2003-09-02
CA2290389A1 (en) 1998-12-17
US6063624A (en) 2000-05-16
AU738348B2 (en) 2001-09-13
AU7389698A (en) 1998-12-30
US20020110914A1 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
US6063624A (en) Platelet suspensions and methods for resuspending platelets
Vettore et al. A new density gradient system for the separation of human red blood cells.
Rock et al. Incorporation of plasticizer into red cells during storage
US20050137517A1 (en) Processing systems and methods for providing leukocyte-reduced blood components conditioned for pathogen inactivation
Rowley et al. Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system
Van de Ouweland et al. Enrichment and cryopreservation of bone marrow progenitor cells for autologous reinfusion
EP2490751A1 (en) Methods and systems for providing red blood cell products with reduced plasma
JPH09509681A (ja) 供血者血液特性の制御
CA1063019A (en) Extracts of the haemopoietic system
CA1299104C (en) Blood cell separation
Schiffer et al. The effect of hydroxyethyl starch on in vitro platelet and granulocyte function
Shimizu et al. Plasma-depleted platelet concentrates prepared with a new washing solution
Gulliksson et al. Preservation of red blood cells: content of microaggregates and di‐2‐ethylhexylphthalate (DEHP) in red blood cells stored in saline‐adenine‐glucose‐mannitol (SAGM) medium
EP0609379A1 (en) Method for freezing engrafting cells
EP0141939A2 (de) Verfahren zur Herstellung von natürlichem Immunoadsorbens
JPH09168585A (ja) 血液バッグシステム
Kurtz et al. Leukocyte‐poor red blood cells prepared by the addition and removal of glycerol from red blood cell concentrates stores at 4 C
Ten Brinke et al. Leukocyte removal efficiency of cell-washed and unwashed whole blood: an in vitro study
Isbister et al. Use of dextran 150 as a macromolecular agent to improve granulocyte yields on the intermittent flow blood cell separator (Haemonetics Model 30)
Patrone et al. In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storage
JPH0643319B2 (ja) 血液成分分離方法およびその器具
JPS5854126B2 (ja) 白血球分離材
Galdames et al. Anticoagulant effects on pure platelet-rich plasma
Latza et al. Platelet function in platelet concentrates during storage: Comparison of two blood cell separators
TRELEAVEN et al. An evaluation of some of the methods currently available for the production of leucocyte‐poor blood

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050513

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050513

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20070531

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20070605

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080626

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090217

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20090608

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090728